TNK-tPA: a new thrombolytic for treatment of acute myocardial infarction.
Johnson
T J
TJ
D004341:Drug Evaluation; D005340:Fibrinogen / Q000187:drug effects / Q000378:metabolism; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007262:Infusions, Intravenous; D009203:Myocardial Infarction / Q000097:blood / Q000188:drug therapy*; D010958:Plasminogen / Q000187:drug effects / Q000378:metabolism; D016032:Randomized Controlled Trials as Topic; D012449:Safety; D000077785:Tenecteplase; D015912:Thrombolytic Therapy / Q000379:methods*; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome
D005343:Fibrinolytic Agents; D005340:Fibrinogen; D010958:Plasminogen; C104096:TNK-tissue plasminogen activator; D010959:Tissue Plasminogen Activator; D000077785:Tenecteplase